SCHEMBL310828

SCHEMBL310828

O=[N+]([O-])c1ccc(N(c2ccc([N+](=O)[O-])cc2)c2ccc([N+](=O)[O-])cc2)cc1

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.83
L3MBTL1 Q9Y468 2/20 0.83
MEN1 O00255 1/20 0.83
CRHBP P24387 1/20 0.83
KMT2A Q03164 1/20 0.83
ATM Q13315 1/20 0.83
CRHR2 Q13324 1/20 0.83
TLR9 Q9NR96 1/20 0.83
MAPT P10636 3/20 0.55
HSD17B10 Q99714 2/20 0.54
ACHE P22303 1/20 0.54
TDP1 Q9NUW8 2/20 0.53
TSHR P16473 2/20 0.53
CYP1A2 P05177 1/20 0.53
CYP3A4 P08684 1/20 0.53
MAPK1 P28482 1/20 0.53
PHLPP2 Q6ZVD8 1/20 0.53
LMNA P02545 1/20 0.52
CES1 P23141 1/20 0.50
CA1 P00915 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8986915 1.00 ALDH1A1 (0.83) ALDH1A1L3MBTL1MEN1CRHBPKMT2A
SCHEMBL3853529 0.91 ALDH1A1 (1.00) ALDH1A1L3MBTL1MEN1CRHBPKMT2A
SCHEMBL17817838 0.91 ALDH1A1 (1.00) ALDH1A1L3MBTL1MEN1CRHBPKMT2A
SCHEMBL1039452 0.91 ALDH1A1 (1.00) ALDH1A1L3MBTL1MEN1CRHBPKMT2A
SCHEMBL31194310 0.89 ALDH1A1 (0.68) ALDH1A1L3MBTL1MEN1CRHBPKMT2A
SCHEMBL29524560 0.89 ALDH1A1 (0.68) ALDH1A1L3MBTL1MEN1CRHBPKMT2A
SCHEMBL6890900 0.89 ALDH1A1 (0.68) ALDH1A1L3MBTL1MEN1CRHBPKMT2A
SCHEMBL15000327 0.89 ALDH1A1 (0.68) ALDH1A1L3MBTL1MEN1CRHBPKMT2A
SCHEMBL9948773 0.89 MAPT (0.70) ALDH1A1L3MBTL1MEN1CRHBPKMT2A
SCHEMBL10336868 0.89 ALDH1A1 (0.68) ALDH1A1L3MBTL1MEN1CRHBPKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119638612-A Super-crosslinking polyamide-imide monomer and preparation method thereof 沈阳化工大学 2025-03-18 CN claimed
CN-119613721-A Super-crosslinked polyamide-imide polymer and preparation method thereof 沈阳化工大学 2025-03-14 CN claimed
CN-114276357-B 2,8, 14-trinitro substituted hexaazanaphthalene monomer and azo-based polymer thereof, preparation method and application 吉林大学 2023-03-28 CN claimed
CN-114276357-A 2,8, 14-trinitro substituted hexaazanaphthalene monomer and azo-based polymer thereof, preparation method and application 吉林大学 2022-04-05 CN claimed
CN-107484436-B Organic field effect transistor with low contact resistance 巴斯夫欧洲公司 2021-09-03 CN claimed
US-10276815-B2 Organic field-effect-transistors with low contact resistance BASF SE (DE) 2019-04-30 US claimed
US-20180026215-A1 ORGANIC FIELD-EFFECT-TRANSISTORS WITH LOW CONTACT RESISTANCE BASF SE (DE) 2018-01-25 US claimed
WO-2016124533-A1 ORGANIC FIELD-EFFECT-TRANSISTORS WITH LOW CONTACT RESISTANCE BASF SE (DE) 2016-08-11 WO claimed
JP-7133437-A None JP disclosed
US-12554051-B2 Optical filter AGC Inc. (JP) 2026-02-17 US disclosed
CN-121282385-A Application of tri (4-nitrophenyl) amine in zinc organic battery 复旦大学 2026-01-06 CN disclosed
CN-121282385-A Application of tri (4-nitrophenyl) amine in zinc organic battery 复旦大学 2026-01-06 CN disclosed
EP-3965738-B1 METHOD FOR PRODUCTION OF LIPOSOMES UNIV DO MINHO (PT) 2025-08-06 EP disclosed
EP-3189021-B1 METATHESIS POLYMERIZATION METHODS UNIV WASHINGTON (US) 2025-05-14 EP disclosed
US-20060217482-A1 Reactive graphitic carbon nanofiber reinforced polymeric composites showing enhanced flexural strength VANDERBILT UNIVERSITY 2006-09-28 US disclosed
US-6887890-B2 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2005-05-03 US disclosed
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-08-28 US disclosed
EP-1291341-A1 COMPOUNDS EXHIBITING THROMBOPOIETIN-LIKE ACTIVITIES CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-03-12 EP disclosed
JP-H07133437-A INFRARED-ABSORBING COMPOUND AND OPTICAL RECORDING MEDIUM PRODUCED BY USING THE COMPOUND CANON INC 1995-05-23 JP disclosed
US-4144260-A Production of aluminum salts of N-nitroso-N-alkyl-hydroxylamines BASF AKTIENGESELLSCHAFT (DE) 1979-03-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities MPL, THPO, TEK ALDH1A1 2042/4885L3MBTL1 1806/4885MEN1 111/4885
US-12554051-B2 Optical filter ODC1, OCIAD2, FTO ALDH1A1 1412/4885L3MBTL1 1378/4885MEN1 2080/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.